P. Chinnapong / Shutterstock.com
US-based Heritage Pharmaceuticals has warned customers that a counterfeit of a brain cancer treatment drug it owns is being sold abroad.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Heritage Pharmaceuticals, counterfeit, US Food and Drug Administration,